Related Articles

• Pathological complete response following cisplatin or carboplatin‑based neoadjuvant chemotherapy for triple‑negative breast cancer: A systematic review and meta‑analysis
• Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?
• Prognostic value of using glucosylceramide synthase and cytochrome P450 family 1 subfamily A1 expression levels for patients with triple‑negative breast cancer following neoadjuvant chemotherapy
• Clinical significance of androgen receptor expression in triple negative breast cancer‑an immunohistochemistry study
• Cyclooxygenase‑2 expression in non‑metastatic triple‑negative breast cancer patients